Company Profiles

driven by the PitchBook Platform

Oligomerix

Description

Developer of therapeutics for Alzheimer's disease and related neurodegenerative disorders. The company focuses on small molecule drug discovery, immunotherapy approaches and biomarker assay development for Alzheimer’s disease.

2006

Founded

PRIVATE

Status

1-10

Employees

Later Stage VC

Latest Deal Type

$400k

Latest Deal Amount

$5.91M

Total Amount Raised

Description

Developer of therapeutics for Alzheimer's disease and related neurodegenerative disorders. The company focuses on small molecule drug discovery, immunotherapy approaches and biomarker assay development for Alzheimer’s disease.

Website:

www.oligomerix.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Drug Discovery

Other Industries

Other Pharmaceuticals and Biotechnology
Biotechnology

Primary Office

3960 Broadway Suite 340D New York, NY 10032United States +1 (212) 568-0365
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Oligomerix's full profile, request a free trial.

Oligomerix Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Oligomerix Cap Table

Stock# of Shares
Authorized
Par ValueDividend Rate (%)Original
Issue Price
LiquidationLiquidation
Pref. Multiple
Conversion
Price
% Owned

Oligomerix Investors (3)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Durand Venture AssociatesVenture CapitalMinority000 0000000 0000
Individual InvestorAngel (individual)Minority000 0000000 0000
Wheatley PartnersPE/BuyoutMinority000 0000000 0000
Durand Venture Associates Venture Capital
Individual Investor Angel (individual)
Wheatley Partners PE/Buyout

Oligomerix Executive Team (3)

NameTitleBoard
Seat
Contact
Info
James Moe Ph.DCo-Founder, President, Director, Principal Investigator & Chief Executive Officer
Jack PasiniDirector & Chief Commercial Officer
Eliot DavidowitzCo-Founder & Chief Scientist
James Moe Ph.D Co-Founder, President, Director, Principal Investigator & Chief Executive Officer
Jack Pasini Director & Chief Commercial Officer
Eliot Davidowitz Co-Founder & Chief Scientist

Oligomerix Board Members (4)

NameRepresentingRoleSinceContact
Info
David Dantzker MDWheatley PartnersGeneral Partner000 0000
Douglas DurandDurand Venture AssociatesFounder and Managing Director000 0000
Jack PasiniOligomerixDirector & Chief Commercial Officer000 0000
Victor MicatiSelfChairman000 0000
David Dantzker MD General Partner Wheatley Partners
Douglas Durand Founder and Managing Director Durand Venture Associates
Jack Pasini Director & Chief Commercial Officer Oligomerix
Victor Micati Chairman Self
Request full access to PitchBook